lobbying_activities: 1270350

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1270350	d5ab8734-5d32-4d1b-8dad-fd2bbd21cc1f	Q2	KNIGHT CAPITOL CONSULTANTS	40036301	GENZYME CORPORATION	2012	second_quarter	PHA	S. 606, Creating Hope Act of 2011, S. 296/H.R. 2245, Preserving Access to Life-Saving Medications Act Reauthorization of the Prescription Drug User Fee Act (H.R. 5651/S. 3187) H.R. 4132, Faster Access to Specialized Treatments Act/S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatment (TREAT) Act	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2012-07-18T15:00:36.317000-04:00